Diagnosis and treatment of pain in small-fiber neuropathy

Current Pain and Headache Reports

Volumn 15, Issue 3, 2011, Pages 193-200

  Hovaguimian, Alexandra ^a   Gibbons, Christopher H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Neuropathy; Pain; Peripheral nerve; Small fiber

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; DIPHENHYDRAMINE; DULOXETINE; GABAPENTIN; IMIPRAMINE; LIDOCAINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALLODYNIA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BEDTIME DOSAGE; BLEEDING; BREAKTHROUGH PAIN; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CRYOTHERAPY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ELECTROCARDIOGRAM; ELECTROMYOGRAPHY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERESTHESIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTHERMIC THERAPY; IMPAIRED GLUCOSE TOLERANCE; INTERSTITIAL LUNG DISEASE; LIVER TOXICITY; LOEFFLER PNEUMONIA; MEDICAL HISTORY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NEUROPHYSIOLOGY; PAIN; PANCREATITIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; QUANTITATIVE SENSORY TESTING; QUANTITATIVE SUDOMOTOR AXON REFLEX TESTING; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SKIN BIOPSY; SMALL FIBER NEUROPATHY; STEVENS JOHNSON SYNDROME;

ANALGESICS; ANIMALS; HUMANS; NERVE FIBERS; NEURALGIA; PAIN; PAIN MANAGEMENT; PERIPHERAL NERVES; TREATMENT OUTCOME;

EID: 79955917862     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-011-0181-7     Document Type: Review

References (51)

1. Gregg EW, Gu Q, Williams D, de Rekeneire N, Cheng YJ, Geiss L, et al. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res Clin Pract. 2007;77:485-8. (Pubitemid 47214587)
2. Tavee J, Zhou L. Small fiber neuropathy: a burning problem. Cleve Clin J Med. 2009;76:297-305. This article is a good review of the symptoms and diagnosis of small-fiber neuropathy.
3. Hsieh ST. Pathology and functional diagnosis of small-fiber painful neuropathy. Acta Neurol Taiwan. 2010;19:82-9. This article is a good review of recent updates to the diagnosis of small-fiber neuropathy.
4. Singer W, Spies JM, McArthur J, Low J, Griffin JW, Nickander KK, et al. Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology. 2004;62:612-8. (Pubitemid 38252804)
5. Dabby R, Vaknine H, Gilad R, Djaldetti R, Sadeh M. Evaluation of cutaneous autonomic innervation in idiopathic sensory smallfiber neuropathy. J Peripher Nerv Syst. 2007;12:98-101. (Pubitemid 46906331)
6. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108-11. (Pubitemid 36070653)
7. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve. 2001;24:1225-8. (Pubitemid 32762152)
8. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. 1999;6:347-63. (Pubitemid 29496214)
9. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diab Care. 2001;24:1448-53. (Pubitemid 33716436)
10. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu- Tirgoviste C, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341-50.
11. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med. 2004;21:252-5. (Pubitemid 38299619)
12. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst. 2009;14:257-67. This article reviews the data surrounding hyperlipidemia and the development of diabetic neuropathy.
13. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58:1634-40. This article highlights the dramatic changes in our understanding of the pathophysiology of diabetic neuropathy that are occurring.
14. Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534-41. This article describes the effects of rapid glycemic control, previously referred to as insulin neuritis, on the development of a severe small-fiber neuropathy manifesting with both pain and autonomic dysfunction.
15. Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58:115-9. (Pubitemid 34041947)
16. Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. Diagnosis and management of HIV-associated neuropathy. Neurol Clin. 2008;26:821-32. (Pubitemid 352020492)
17. Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST. Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology. 2002;59:1094-8.
18. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barre syndrome: pathology and clinical correlations. Brain. 2003;126:386-97.
19. Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, et al. Celiac neuropathy. Neurology. 2003;60:1581-5. (Pubitemid 36618081)
20. Brannagan III TH, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol. 2005;62:1574-8. (Pubitemid 41434563)
21. Gorson KC, Herrmann DN, Thiagarajan R, Brannagan TH, Chin RL, Kinsella LJ, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79:163-9. (Pubitemid 351236547)
22. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000;55:1115-21.
23. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65:629-38.
24. Ramchandren S, Lewis RA. Monoclonal gammopathy and neuropathy. Curr Opin Neurol. 2009;22:480-5.
25. Blum AS, Dal Pan GJ, Feinberg J, Raines C, Mayjo K, Cornblath DR, et al. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors. Neurology. 1996;46:999-1003. (Pubitemid 26134641)
26. Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A, et al. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol. 2006;59:816-24. (Pubitemid 43673159)
27. Tan CH, Chen YF, Chen CC, Chao CC, Liou HH, Hsieh ST. Painful neuropathy due to skin denervation after metronidazole-induced neurotoxicity. J Neurol Neurosurg Psychiatry. 2010. doi:10.1136/jnnp.2009.194118.
28. Goransson LG, Tjensvoll AB, Herigstad A, Mellgren SI, Omdal R. Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. Arch Neurol. 2006;63:401-4.
29. Chai J, HerrmannDN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology. 2005;65:925-7. (Pubitemid 41362143)
30. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine. 1992;71:59-72.
31. Camdessanche JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain. 2002;125:166-75.
32. Singleton JR, Bixby B, Russell JW, Feldman EL, Peltier A, Goldstein J, et al. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst. 2008;13:218-27. This is an important publication that reports a novel quantitative neurologic assessment specifically for the diagnosis of small-fiber neuropathy.
33. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248-57. (Pubitemid 38353047)
34. Peltier A, Smith AG, Russell JW, Sheikh K, Bixby B, Howard J, et al. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve. 2009;39:529-35.
35. Freeman R, Chase KP, Risk MR. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology. 2003;60:465-70.
36. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia-Larrea L, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17:1010-8.
37. Chao CC, Tseng MT, Lin YJ, Yang WS, Hsieh SC, Lin YH, Chiu MJ, Chang YC, Hsieh ST. Pathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentials. Diabetes Care. 2010;33:2654-9.
38. Low VA, Sandroni P, Fealey RD, Low PA. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57-61.
39. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst. 2010;15:202-7.
40. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17:903-9. This is a critical review of all the available data on the use of skin biopsies for the assessment of small-fiber neuropathy.
41. Gibbons CH, Griffin JW, Polydefkis M, Bonyhay I, Brown A, Hauer PE, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology. 2006;66:256-8. (Pubitemid 43970168)
42. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-51. (Pubitemid 350051570)
43. Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-1e88.
44. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3-S14.
45. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12:13-21. This is a comprehensive medication review of different agents used to treat neuropathic pain.
46. Acevedo JC, Amaya A, Casasola OL, Chinchilla N, De GM, Florez S, et al. Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts. J Pain Palliat Care Pharmacother. 2009;23:261-81.
47. Bohlega S, Alsaadi T, Amir A, Hosny H, Karawagh AM, Moulin D, et al. Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. J Int Med Res. 2010;38:295-317.
48. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153-69. This is a very thorough review of the treatment of neuropathic pain, highlighting the strength andweakness of pharmacologic agents across a spectrum of diseases and calculating the number needed to treat.
49. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003;60:1284-9. (Pubitemid 36460983)
50. Kroemer HK, Eichelbaum M. "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Life Sci. 1995;56:2285-98.
51. Ho TW, Backonja M, Ma J, Leibensperger H, Froman S, Polydefkis M. Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies. Pain. 2009;141:19-24.